Valentia Biopharma Overview
Latest Deal Type
Out of Business
Valentia Biopharma General Information
Description
Provider of a novel drug discovery platform designed to generate a broad pipeline of first-in-class drugs. The company's novel drug discovery platform analyzes thousands of compounds and have a capacity to reproduce the process of massive molecule testing in vivo using Drosophila individuals enabling the development of additional drugs to treat human diseases.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Valentia Biopharma Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 2. Out of Business |
01-Feb-2016 |
|
|
|
Completed |
Out of Business |
| 1. Early Stage VC |
26-Jun-2008 |
|
|
|
Completed |
Startup |
Valentia Biopharma Executive Team (2)
| Name |
Title |
Board Seat |
Contact Info |
| Rebeca Lucas |
Co-Founder & Chief Executive Officer |
|
|
| Manuel Perez-Alonso Ph.D |
Co-Founder & Scientific Director |
|
|